ArticleFrontiers in pharmacology2025
A real-world pharmacovigilance study of efgartigimod alfa in the FDA adverse event reporting system database.
Yunlin Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papertrialcites it